Diagnostic importance of S100A9 and S100A12 in breast cancer

Gunaldi M., OKUTURLAR Y., GEDİKBAŞI A., Akarsu C., Karabulut M., Kural A.

BIOMEDICINE & PHARMACOTHERAPY, cilt.76, ss.52-56, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.biopha.2015.10.029
  • Dergi Adı: BIOMEDICINE & PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.52-56
  • Anahtar Kelimeler: Breast cancer, S100A9, S100A12, Inflammation, Target marker, HEPATOCELLULAR-CARCINOMA, TUMOR DIFFERENTIATION, PROTEINS S100A8, EXPRESSION, ADENOCARCINOMA, TISSUE, ROLES, IDENTIFICATION, INFLAMMATION, METASTASIS
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: The most frequent cause of cancer deaths throughout the world is breast cancer (BC). Therefore, preventing, diagnosing and treating BC has gained importance. S100 protein probably plays an important role in carcinogenesis, cancer development, and metastasis. In this study, we aimed at diagnostic and clinic-pathological importance of serum levels of S100A9 and S100A12 with known cytokine-like pro-inflammatory effects in BC.